Federico
Martinón Torres
Universitat de Barcelona
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Universitat de Barcelona (10)
2024
2023
-
A multi-platform approach to identify a blood-based host protein signature for distinguishing between bacterial and viral infections in febrile children (PERFORM): a multi-cohort machine learning study
The Lancet. Digital health, Vol. 5, Núm. 11, pp. e774-e785
2022
-
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
The Lancet, Vol. 399, Núm. 10340, pp. 2047-2064
-
Identifying the research, advocacy, policy and implementation needs for the prevention and management of respiratory syncytial virus lower respiratory tract infection in low- and middle-income countries
Frontiers in Pediatrics, Vol. 10
-
Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort
Clinical Rheumatology, Vol. 41, Núm. 12, pp. 3759-3768
2021
-
Interferon-Gamma Release Assays Differentiate between Mycobacterium avium Complex and Tuberculous Lymphadenitis in Children
Journal of Pediatrics, Vol. 236, pp. 211-218.e2
2020
-
Meningococcal disease: Can we predict the unpredictable?
Medicina Clinica, Vol. 154, Núm. 1, pp. 20-22
-
Reply to “Diagnostic criteria sets sensitivity”
Journal of Allergy and Clinical Immunology: In Practice
2018
-
Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC4 E): the ALIC4 E protocol
BMJ open, Vol. 8, Núm. 7, pp. e021032
2017
-
Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: Update based on the clinical evidence in Spain
BMC Infectious Diseases, Vol. 17, Núm. 1